Company Filing History:
Years Active: 2016
Title: Holger J Moller: Innovator in CD163-Binding Conjugates
Introduction
Holger J Moller is a notable inventor based in Aabyhoj, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents. His work focuses on the interaction between haptoglobin-haemoglobin complexes and CD163 receptors, which has implications for medical therapies.
Latest Patents
Holger J Moller holds a patent for "CD163-binding conjugates." This invention relates to the haptoglobin-haemoglobin (Hp-Hb) complex or a part thereof, which is operably linked to a substance capable of binding a CD163 receptor. The patent also covers a CD163 variant, either membrane-bound or soluble, that can bind at least one haptoglobin-haemoglobin complex. This innovation has potential therapeutic applications, enhancing the understanding of how these complexes can be utilized in treatment.
Career Highlights
Holger J Moller is associated with Affinicon Aps, where he continues to advance his research and development efforts. His work has led to a deeper understanding of the biochemical interactions that can be harnessed for therapeutic purposes. With 1 patent to his name, he is recognized for his contributions to the field.
Collaborations
Holger collaborates with Soren Moestrup, a fellow researcher who shares his interest in the biochemical mechanisms underlying haptoglobin-haemoglobin interactions. Their partnership enhances the research output and innovation potential within their field.
Conclusion
Holger J Moller is a distinguished inventor whose work on CD163-binding conjugates represents a significant advancement in therapeutic research. His contributions continue to influence the field of biochemistry and hold promise for future medical applications.